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Abstract: Conformational flexibility in molecules can give rise to a range of functional group termina-
tions at crystal surfaces and dynamic disorder in the bulk. In this work, we explore the conformational
behavior of the drug molecule lovastatin in the crystallographically disordered solid and at crystal
surfaces through a combination of computational modeling and spectroscopy. Gas-phase and peri-
odic quantum-chemical calculations are used to study the potential energy surface associated with
rotatable bonds to examine the disorder in bulk. These calculations are combined with vibrational
and X-ray photoelectron spectroscopy measurements to obtain insight into the conformations in bulk
and at the surface. Our MD simulations show that the bulk disorder is driven by cooperative motion
of the butyl group on the S-butanoate moiety along one crystallographic direction beyond a unit
cell. The calculations show that the O-H group can rotate relatively freely between two low-energy
conformers in the gas phase but is locked in position by intermolecular H-bonding interactions in the
bulk crystal, and we find tentative spectroscopic evidence for the second conformer being present
at the surface. We also comment on the relative utility of these different techniques for studying
molecular conformation in bulk and at surfaces and highlight possible areas for future developments.
Keywords: lovastatin; molecular conformation; infrared spectroscopy; Raman spectroscopy; X-ray
photoemission spectroscopy; density functional theory calculations; solid-state molecular dynamics
1. Introduction
The conformations of functional groups terminating crystal surfaces can influence
important material properties including crystal morphology [1,2], wettability [3–5], dissolu-
tion rates [6] and adhesive properties [7]. These properties are often particularly important
for pharmaceuticals as they affect both the downstream processing and the bioavailabil-
ity of the end product [8]. Flexible molecules therefore pose a challenge both because
they can present functional groups in different orientations at surfaces, and because the
presence of multiple conformations in the bulk can influence intra- and intermolecular
interactions, crystal packing and give rise to dynamic disorder. A holistic understanding of
particle properties requires an understanding of the intrinsic conformational flexibility of
the molecule and how this impacts on any bulk dynamic disorder as well as the chemical
behavior of functional groups present at the crystal surfaces and the presence of impurities
on the true particle surface.
Flexible molecules with multiple bond torsions are capable of forming several “con-
formers”, defined as molecular structures with distinct topologies that correspond to
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energetic minima on the structural potential energy surface (PES) [9]. The need to under-
stand the conformational behavior of flexible molecules has led to widespread interest
in exploring the energetics associated with conformational changes, understanding the
resulting polymorphism [9,10], identifying spectroscopic signatures of different conform-
ers [11–13] and applying these insights to crystal structure prediction [14]. Analysis of
polymorphs in the Cambridge Structural Database (CSD) indicated that if two topologies
result from a difference in a torsion angle ∆θ > 120◦, they can be considered “conforma-
tional polymorphs” [9]. These conformers tend to have energy differences in the order
of 10 kcal mol−1, undergo slow inter-conversion in solution and therefore crystallize as
distinct polymorphs [15]. If, on the other hand, conformers are separated by a small energy
barrier and interconvert rapidly, the conformational flexibility is not likely to affect the
polymorphic outcome of a crystallization [15] and may instead lead to the presence of
dynamic disorder in a solid.
The structural PES of a molecule in the gas phase can, in most cases, be mapped
directly to the conformations observed in the solid state [9] and have been used to identify
new conformers and to calculate spectroscopic signatures to help assign experimental
data [16–20]. Rotations of, e.g., CH3, NH2 and OH groups are usually not considered
during conformational analyses, as typically only a thermal average is observed from
crystallography. These can, however, play a vital role in the stability of a crystal structure
through “conformational adjustments” that facilitate better overall crystal packing in
exchange for a small energy penalty.9 These changes can be studied using vibrational (e.g.,
infrared—IR) and nuclear magnetic resonance (NMR) spectroscopy [21,22], and both IR
spectroscopy [23] and the NMR nuclear Overhauser effect (NOE) [21,22] have been used to
study the conformations of peptides and proteins. Conformational flexibility giving rise to,
e.g., molecular reorientation [24,25] and dynamic disorder [26] in organic crystals can be
readily investigated using molecular dynamics (MD) simulations, while lattice dynamics
modeling can predict the natural thermal motion of atoms and crystal vibrations to provide
a point of reference for experimental measurements [27,28]. Such simulations can both help
to interpret spectroscopic data [26] and provide enhanced insight into, e.g., the changes to
molecular interactions that result from conformational changes due to bond torsions.
In addition to the bulk conformations, there is also the separate question of the
conformation of molecules at the crystal surfaces. This is particularly important given that
the functional groups exposed at the surface determine the interaction with the environment
and therefore control physical properties such as adhesion [7], crystal growth [29] and
dissolution rates [30].
We recently demonstrated that polarized Raman spectroscopy can be used to establish
the nature and conformation of functional groups at the dominant crystal surfaces of
aspirin [27]. Both IR operating in attenuated total reflection (ATR) mode using evanescent
waves and Raman using long-wavelength lasers have a penetration depth of microns to
mm in an organic crystal, and thus do not provide information about functionality present
within nm of the surface. X-ray photoelectron spectroscopy (XPS), which typically probes
the uppermost 10 nm of a material and can prove useful when the chemical environment at
the surface, is very different to that in the bulk. XPS has, for example, previously been used
to establish the conformations of polymers [31] and the protonation states of molecules in
the solid state [32].
In this study, we explore the conformational flexibility of the drug molecule lovas-
tatin. Lovastatin (C24H36O5) is currently used to treat poroketaratosis [33] and hyper-
chloestrolemia and, more recently, has been explored for the treatment of hypertension.
Therapeutically, lovastatin is known to lower the risk of heart disease and strokes in patients
with other comorbidities [34] but has very low solubility and bioavailability. An improved
understanding of the structure–property relationships in this material is therefore needed
to improve its physical properties [35,36] and manufacturability [37,38]. The lovastatin
molecule has 65 atoms and eight stereogenic centers and thus can, in principle, exhibit
considerable conformational flexibility. Lovastatin crystallizes into the orthorhombic space
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group P212121 with four molecules in the unit cell [2,39,40]. Like its analogue simvas-
tatin [26], lovastatin exhibits both positional and dynamic disorder of the S-butanoate arm
in the bulk crystal structure [40], which was only recently resolved [2]. In the bulk, we
would expect the conformational flexibility to be restricted by intra- and intermolecular
interactions. Inelastic neutron scattering studies have identified the presence of stabilizing
non-covalent CH· · ·HC and CH· · ·O interactions in the solid state, but were unable to re-
solve the dynamics of the O-H bond [34]. On the other hand, molecules at the surface, with
fewer restricting interactions, could, in theory, exhibit a broader range of conformations.
In this work, we use a combination of quantum-chemical calculations, MD simula-
tions and computational spectroscopy to explore the conformational flexibility of lovastatin
in the gas phase and in bulk. We compare these results to measurements on crystalline
powder samples using ATR-FTIR, FT–Raman and near-ambient pressure (NAP) XPS to
attempt to shed light on the functional group terminations present on the crystal sur-
face and to examine the conformation adopted by the lovastatin molecules at the true
surface and the sub-surface. We also assess the possible presence of impurities from the
manufacturing process.
2. Materials and Methods
2.1. Experimental
2.1.1. Materials
Polycrystalline lovastatin powder (>99%) was purchased from Molekula, Durham,
UK and used without further processing. The manufacturer indicates ~1 wt. % impurities,
of which 0.5 wt. % are a related compound obtained as a side product from the synthesis.
2.1.2. Infra-Red Spectroscopy
IR spectra were collected using a Thermo Fischer Nicolet FTIR (UK) in attenuated
total reflectance (ATR) mode through a diamond crystal (650–4000 cm−1, 4 cm−1 resolution,
32 scans integrated per spectrum).
2.1.3. FT–Raman Spectroscopy
FT–Raman spectra were collected using a Bruker MultiRam (Coventry, UK) equipped
with a 1064 nm laser and a liquid nitrogen-cooled Ge detector (30–3600 cm−1, 4 cm−1
resolution, 4 scans integrated per spectrum). The spectra were normalized and 7-point FFT
smoothing applied to remove high-frequency thermal noise from the detector.
2.1.4. X-Ray Photoelectron Spectroscopy (XPS)
XPS measurements were performed with a SPECS EnviroESCA (Scanwel, Bala, Gwynedd,
UK) using a monochromated Al Kα X-ray source operating at 42 W and a Phoibos 150 NAP
analyzer with delay-line detector. The as-received powder was lightly pressed into a pellet
and mounted with adhesive carbon tape onto an SEM stub, which was placed on the
sample stage. The sample was positioned at a working distance of ~300 µm from the
nozzle to the transfer lens stage and was illuminated with a beam spot size of ~300 µm.
Gas-phase charge compensation was achieved with 5 mbar Ar in the analysis chamber
during measurements. Survey spectra were collected in 1 scan with 100 eV pass energy,
0.5 eV step size and 0.1 s dwell time, while high-resolution core-level spectra were collected
in 4 scans with 20 eV pass energy, 0.1 eV step size and 0.4 s dwell time. Peak positions
were charge-corrected in binding energy by aligning the aliphatic contribution to the C1s
spectrum by −2.75 eV to 285.0 eV and applying the same correction to all spectra. Data
analysis was done with CasaXPS [41] Version 2.3.22PR1.0. Core-level spectra were fit using
a GL(30) line function for all components and a linear background function.
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2.2. Computational
2.2.1. Gas-Phase Conformational Analysis and Simulated Spectra
Gas-phase optimization and conformational analysis of the lovastatin molecule was
performed using the Gaussian09 code [42] with the B3LYP functional [43] and a 6-31g+(d,p)
basis set [44]. This combination of functional and basis set has been reported to be a good
compromise between cost and accuracy for conformational analyses [45].
As described in the text, for the conformational analyses, we investigated the three
main bond torsions in the molecule, viz. the “alkyl” C-C torsion around the arm with the
pyranyl ring (τ1), rotation of the O-H bond to different orientations (τ2), and the “ester”
C-O torsion about the ester arm (S-butanoate group) (τ3). The torsion angles about these
three groups were varied over a series of fixed angles in 10◦ steps, and all other degrees of
freedom were optimized at each point. The resulting potential energy surface (PES) from
each scan was then inspected to identify the global conformational minimum and three
additional low-energy local minima.
The Kohn–Sham orbitals were optimized with the default tolerances of 10−6 and
10−8 a.u. on the maximum and root-mean-square (RMS) changes in the density matrix.
Geometry optimizations were carried out to the default tolerances of 4.5 × 10−4 and
3 × 10−4 a.u. on the maximum and RMS force, and 1.8 × 10−3 and 1.2 × 10−3 a.u. on the
maximum and RMS displacements. The default integration grids were used.
Frequency calculations were performed on the four energy minima to confirm them to
be stationary points and to compute theoretical IR and Raman spectra. The Natural Atomic
Orbitals (NAO) analysis was used to estimate the core atomic energy levels ENAO, which
were taken as binding energies to calculate theoretical XPS spectra [46], i.e.,
BE = −ENAO
We note that this is a rather crude approximation—it assumes that E = 0 is the vacuum
level and that the photoelectron is completely ejected from the molecule, and does not take
into account, e.g., electronic relaxation to stabilize the core hole. In practice, matching the
binding energies to measured spectra required offsets of ~11.5 and 18 eV for the C 1s and O
1s binding energies. Simulated spectra were obtained by convolving the individual NAO
contribution with a Gaussian function with a full width at half maxima (FWHM) of 0.2 eV
to emulate typical instrument broadening, and then summing the resulting series of peak
functions.
The electrostatic potentials and electron densities of the conformers were generated us-
ing Gaussian09 and visualized using the VESTA software [47]. The Multiwfn software [48]
was used to study the reduced density gradients (RDGs), generated on high-quality grids
with ~2 × 106 points, to identify key intramolecular interactions. The isosurfaces were
visualized using the Visual Molecular Dynamics (VMD) software [49] in conjunction with
scripts provided with Multiwfn.
2.2.2. Solid-State Molecular Dynamics and Simulated Spectra
Periodic density functional theory (DFT) calculations were carried out using the
pseudopotential plane wave approach implemented in the Vienna Ab Initio Simulation
Package (VASP) code [50].
Calculations were carried out using the PBE generalized-gradient approximation
(GGA) functional [51] with the DFT-D3 dispersion correction [52] (i.e., PBE+D3). The
electronic structure was modeled using a plane wave basis set with a kinetic energy cutoff
of 800 eV and a Γ-centered Monkhorst–Pack k-point grid [53] with 3 × 1 × 1 subdivisions.
These settings were found through explicit convergence testing to converge the total energy
and external pressure to < 1 meV atom−1 and 1 kbar (0.1 GPa), respectively. Projector
augmented wave (PAW) pseudopotentials [54,55] were used to model the ion cores, with
the H 1s and C/O 2s and 2p electrons included in the valence shell.
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The starting point for our calculations was the most recent experimental crystal
structure with the disorder components removed (CCDC identifier: CEKBEZ01) [2], which
was fully optimized to tolerances of 10−8 eV on the total energy and 10−2 eV Å−1 on the
forces. With these chosen tolerances, optimization with PBE+D3 did not change the cell
volume or lattice constants compared to the starting experimental structure.
To study the disorder in the solid, constant-volume Born–Oppenheimer molecular
dynamics (BOMD) simulations were performed at 300 K in the single unit cell and a
2 × 1 × 1 supercell expansion, for 100 and 25 ps, respectively. The expansion is along
the short lattice vector and was chosen as a balance between system size and minimizing
artefacts from periodic boundary conditions in the dynamics. The simulation temperature
was controlled using a Nosé–Hoover thermostat [56] with the default coupling frequency
of 40 timesteps. To speed up the simulations, the plane wave cutoff was reduced to
600 eV, the k-point sampling was reduced to the Γ point, and the mass of the H atoms
was increased to 2 (i.e., switching H for D) in order to use a larger MD timestep of 1 fs.
Based on explicit convergence tests, the reduced cutoff and k-point sampling produce
errors of 0.2 eV molec−1 (~3 meV atom−1) in the total energy and 5.6 kbar in the pressure,
but lead to a negligible change in the structure, as determined by comparing the pair
distribution functions.
Lattice dynamics calculations were performed on the optimized structure to obtain
the Γ-point phonon frequencies using the supercell finite displacement method [57] im-
plemented in the Phonopy code [58] and a step size of 10−2 Å. The absence of imaginary
modes in these calculations confirmed that the molecules in the optimized crystal structures
are at an energy minimum. The infrared and Raman activities of the modes were then
computed from the eigenvectors using the Phonopy-Spectroscopy package [59]. The Born
effective charge tensors and dielectric constants required to compute the IR and Raman
activities were obtained using the density functional perturbation theory (DFPT) routines
in VASP [60]. For the Raman activities, the dielectric constant derivatives were computed
using numerical differentiation with a two-point finite difference stencil and a step size of
10−2× the eigenvector norm. Simulated IR and Raman spectra were generated as sums of
Lorentzian peak functions using the calculated frequencies and activities and a nominal
full width at half maximum (FWHM) of 10 cm−1.
During the geometry optimization and MD simulations, the PAW projection was
performed in real space and the precision of the charge density grids was set automatically
to avoid aliasing errors. For the MD simulation, the precision was reduced slightly to speed
up the calculations. For the lattice dynamics and DFPT calculations, the PAW projection
was performed in reciprocal space to ensure accurate forces, and an additional support
grid with 8× as many points was used to reconstruct the augmentation charges.
3. Results
3.1. Conformational Flexibility
3.1.1. Gas-Phase Conformational Analysis
To investigate the conformational flexibility in lovastatin, we first carried out a set of
gas-phase calculations to determine the potential energy surfaces (PESs) associated with
three major rotatable bonds in the molecule (Figure 1a). A 2D version of the molecular
representation can be found in Figure 1e.
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Figure 1. Gas-phase conformational analysis of the lovastatin molecule. (a) Molecular structure highlighting the three
torsion angles τ1–τ3 investigated in the conformational analyses. (b) Potential energy surface (PES) for the “alkyl” torsion
τ1 in the pyranyl group. (c) PES for the hydroxyl rotation τ2 in the pyranyl group. (d) PES for the “ester” torsion τ3 in
the S-butanoate group. The analyses in (b)–(d) identify four low-energy conformers, which are labeled 1–4 in order of
increasing energy. Three additional minima, with too high an energy to be appreciably populated at room temperature, are
marked with asterisks. Plots (a)–(d) also show the occurrence probabilities of the conformations on each PES computed
based on Boltzmann distributions at 100–300 K. The lines are color-coded by temperature from blue (low T) to orange
(high T). (e) Molecular scheme highlighting atom labels and the three bonds rotated for the PES studies.
As can be seen in Figure 1b–d, the PES scans identify a global minimum and three new
low-energy local minima. Two of the new minima were found from the alkyl torsion scan
and the third from the hydroxy group orientation scan, while the ester torsion did not show
any additional low-energy conformers. The four minima are identified as Conformer 1–4
on the PES scans and labeled in the order of their relative energies from lowest to highest.
While we believe that the ab initio conformational analysis has identified a possible global
minimum, multi-dimensional PES scan or a gas-phase MD analysis might reveal others. We
believe that the present structure, being closest to that of the bulk crystal structure, however,
is sufficient for the present study. The relative energies ∆E and torsion angles τ1–τ3 for
each of the conformers are given together with other selected geometric parameters in
Table 1. The PES scans also identified three additional high-energy local minima, denoted
by asterisks in Figure 1b–d, but these are sufficiently high in energy that we would not
expect them to be appreciably populated at room temperature. The PES shown in Figure 1d
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also indicates a high energy barrier for the rotation of the butanoate group, as previously
reported [34].
Table 1. Relative energies, occurrence probabilities at T = 290 K, dihedrals τ1–τ3 and selected bond lengths and angles for
the four low-energy gas-phase conformers of lovastatin identified in Figure 1.
Conformer 1 Conformer 2 Conformer 3 Conformer 4
∆E (kJ mol−1) 0 2.54 4.54 5.70
Occurrence probability pn at T = 290 K 0.627 0.218 0.095 0.059
τ1 (◦) 177 180 177 92.1
τ2 (◦) −61.9 60.5 62.2 −61.3
τ3 (◦) 0.4 −2.0 −2.9 3.8
Φ(C19-C28-C20-C17) (butyl) (◦) 66.0 66.1 66.0 66.8
Φ(C10-C28-C20-C17) (butyl, hexahydronaphthenyl) (◦) −172.3 −167.3 −167.6 −165.1
Φ(O48-C11-C5-C4) (between S-butanoate/pyrnyl groups) (◦) 90.7 91.2 90.3 92.1
d(C=O) (S-butanoate) (Å) 1.217 1.217 1.217 1.216
d(C-O) (S-butanoate) (Å) 1.352 1.351 1.352 1.357
d(C=O) (pyranyl) (Å) 1.211 1.210 1.211 1.212
d(C-O) (pyranyl) (Å) 1.353 1.357 1.353 1.351
d(O-H) (pyranyl) (Å) 0.966 0.967 0.966 0.966
While we found no significant differences in the bond lengths between the four con-
formers, each has distinctly different dihedral angles. The alkyl torsion τ1 represents the
angle that the pyranyl group makes with the hexahydronaphathenyl group. The global min-
imum Conformer 1 has a near-identical dihedral to Conformer 3, and the major difference
between them is the angle that the butyl group makes with the hexahydronaphththenyl
group (Φ(C10-C28-C20-C17)). The τ1 dihedrals of Conformers 2 and 3 differ by only 2◦ but
the hydroxyl group is rotated by 180◦ (τ2). In Conformer 4, the τ1 dihedral is ~90◦ smaller
than the other conformers, which results in the S-butanoate and the pyranyl groups run-
ning parallel to each other. An overlay of the structures of the four low-energy conformers
and a molecule extracted from the experimental crystal structure can be found in Figure S1
(Supplementary Materials).
Given the relative energies ∆En of the n = 4 conformers, the occurrence probability Pn







where kB is the Boltzmann constant and Z(T) is the thermodynamic partition function. At
298 K, this analysis predicts that 62. % of a sample of isolated lovastatin molecules would
adopt Conformer 1, 21.8% would adopt Conformer 2, which is 2.54 kJ mol−1 higher in
energy, and a much smaller 9.5 and 5.9% would adopt Conformers 3 and 4 due to their
higher relative energies of 4.54 and 5.70 kJ mol−1, respectively. We would therefore expect
the main flexibility in the molecule to be around the orientation of the OH group and
the secondary butyl group. Previous studies [34] using inelastic neutron scattering and
solid-state NMR suggested that the main contributions to the spectroscopic features are
from methyl dynamics, however, but were unable to resolve the OH dynamics. As shown
in the PES scans in Figure 1, the occurrence probabilities of the higher-energy conformers
are very strongly temperature-dependent. Excepting the OH group rotation τ2, the bond
torsion listed in Table 1 also does not suggest any angle change greater than 120◦, which
explains why lovastatin does not show conformational polymorphism [9].
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3.1.2. Solid-State Molecular Dynamics
To investigate the conformational flexibility giving rise to the dynamic disorder in bulk
lovastatin, we first performed short MD simulations at 300 K on the lovastatin unit cell and a
2× 1× 1 supercell expansion (Figure 2). Plotting the total energy, temperature, cell pressure
and root-mean-square displacement (RMSD) over the two trajectories confirms that the
100 and 25 ps simulation times for the two models were sufficient to reach equilibration
(Figures S2–S5).
Figure 2. Molecular dynamics simulation of the lovastatin crystal. (a) Comparison of the pair
distribution functions g(r) of the optimized crystal structure (top) and averaged over the MD
trajectories run with a single unit cell and in a 2 × 1 × 1 supercell (middle/bottom). For each of
the MD trajectories, the average g(r) is shown in red, and functions averaged over smaller time
windows of 500/100 ps are shown as colored lines from blue to cyan. The PDFs were generated
using a Gaussian broadening with a nominal linewidth σ of 0.05 Å. (b)/(c) Histograms of the atomic
positions in the single-cell (b) and supercell (c) models projected onto the bc plane, with the atomic
positions in the optimized structure overlaid as balls and sticks for comparison.
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The static (optimized) structure and the dynamic structures during the MD simulations
were compared by computing the pair distribution functions (PDFs) g(r) (Figure 2a). The

















where N is the number of atoms, ρ = N/V is the atomic number density, the double
sum runs over atomic pairs i and j separated by a distance rij and the bond distances are
accumulated into a histogram with a bin width ∆r. The g(r) expresses the probability
of finding an atom at a distance r from a reference atom relative to that expected for a
homogenous distribution at the average atomic density. Peaks in the g(r) thus indicate
preferred interatomic distances.
In the optimized lovastatin crystal, the complex molecular structure results in sharp
features at 1.1, 1.5, 1.8, 2.2 and 2.6 Å, corresponding to five distinct neighbor distances.
Comparing the PDFs of the optimized structure to those averaged over the two MD
simulations appears to show only thermal broadening, and does not provide any direct
evidence for significant conformational changes that might show up, e.g., as shoulder
features. Comparison of PDFs averaged over shorter time windows again confirms rapid
structural equilibration from the initial model.
We further examined the thermal motion by computing histograms of the atomic posi-
tions projected along the crystallographic b and c axes over the two trajectories (Figure 2b,c).
Comparison of the two plots suggests a considerably larger range of thermal motion in the
trajectory run with the larger supercell, despite there being little evidence for changes in
the local structure in the PDFs. The supercell is expanded along the short crystallographic
a axis, so we infer from this that the motion of adjacent molecules along this direction
is correlated such that movement of a molecule in one unit cell facilitates movement of
molecules in the neighboring cells.
We also measured a set of dihedral angles and bond lengths describing the conforma-
tion of a representative molecule in each trajectory over the simulation, using the Visual
Molecular Dynamics (VMD) software [49]. We measured the τ1–τ3 dihedrals investigated
in the gas-phase conformational analyses (c.f. Figure 1a) together with an angle quantifying
the orientation of the butyl group on the S-butanoate moiety. We also tracked the O-H· · ·O
H-bond length and an angle defining the O-H group orientation. These data are shown in
Figures S6–S8.
While we do observe some thermal variation in the τ1–τ3 dihedrals during the simula-
tions, they oscillate about an average value. There is, however, clear evidence for the butyl
group adopting two distinct conformations over the two trajectories, suggesting that this is
the most flexible part of the molecule in the solid state, as suggested by inelastic neutron
scattering data [34]. We observe two conformational changes in the 100 ps trajectory of the
single unit cell, and one conformational change during the 25 ps trajectory of the supercell.
The higher frequency of changes in the larger supercell may again be taken as evidence
that these conformational changes are enabled by cooperative movements of molecules
along the a direction, in keeping with the histogram plots in Figure 2b,c. However, con-
formational changes are inherently stochastic, so this conclusion should be treated with
caution given the short simulation times.
Based on the gas-phase calculations, we would expect also to see changes in the
orientation of the O-H group. However, our analysis of the MD trajectories shows that the
O-H group has a strong preference for remaining in one orientation, with changes in the
torsion angle and the O-H· · ·O H-bond distance suggest regular, unsuccessful attempts at
reaching the rotated conformer. This is likely due to the intermolecular H-bond formed
in the solid state, which is not present in the gas-phase models, adjusting the PES for
the rotation. We also used the H-bond analysis routine in VMD to count the number
of H-bond interactions in the simulation cell using a distance cutoff of 3 Å (Figure S9).
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This shows that the smaller single-cell model generally has one H-bond per molecule,
i.e., all bonds are saturated, whereas the larger supercell model generally has slightly less
than one 1 H-bond per molecule. This suggests that, as for the butyl conformation, the
dynamics of molecules in neighboring unit cells along the shorter a direction may enable
some additional conformational flexibility around the O-H group.
It is, of course, also possible that our simulation is simply not long enough to observe
conformational changes. Assuming that a conformational change can be modeled as a first-
order reaction, the number of events n per unit time can be estimated from the Arrhenius
equation as:
n = A exp[−EA/RT] (1)
where A is the attempt frequency, EA is the activation energy and R is the gas constant.
The gas-phase conformational analyses discussed in the following section suggest energy
barriers of between 6 kJ mol−1 for rotation of the OH group to 60 kJ mol−1 for the rotation of
the S-butanoate about the C-O bond (c.f. Figure 1). If one assumes that the conformational
changes are driven by vibrations with a “ballpark” frequency of 1000 cm−1 (30 THz), the
corresponding values of n would range from 2.7 to 10−9 ps−1. We might therefore expect to
see the low-energy OH conformational change many times during the simulation, but we
would need to simulate for at least nine orders of magnitude longer (i.e., milliseconds) to
see the S-butanoate conformation change, if this motion is indeed possible in the solid state.
The fact that we do not see evidence for complete OH rotation, in either of the supercells,
again strongly suggests that the activation energy may be significantly higher in the solid
state than in the gas phase.
3.1.3. Intramolecular Interactions
Lovastatin is a large molecule with a range of possible torsions in the side chains,
which can result in different types of intramolecular interactions in different conformers.
Analysis of the electrostatic potentials (ESPs) of the low-energy conformers identified
from the gas-phase PES scans shows that all four show subtle electrostatic interactions
between the S-butanoate C-O oxygen and the C-OH oxygen on the pyranyl group with H
atoms on adjacent C atoms (Figure S10).
We also studied the non-covalent interactions (NCI) in the four conformers from the
sign of the reduced density gradient (RDG; Figure 3). The isosurfaces in Figure 3 are
colored based on the sign of the second derivative of the electron density (the Laplacian)
such that blue indicates H-bonding interactions (-ve Laplacian), green indicates van der
Waals (vdW) interactions (Laplacian close to zero), and red indicates steric interactions
(+ve Laplacian). The four conformers show an increase in vdW interactions (indicated by
green isosurfaces) between the S-butanoate and pyranyl groups with increasing conformer
energy. This relates directly to the smaller τ1 dihedral in Conformer 4, as noted above.
There are also increased vdW interactions between the butyl group of the S-butanoate and
the hexahydronaphathaenyl group in Conformer 4.
Taken together, these results show that the conformational PES of lovastatin is gov-
erned mainly by vdW interactions and does not have a strong electrostatic interaction
that preferentially stabilizes the higher-energy conformations or results in any partic-
ular intramolecular configurations being “locked in”, as is observed in some organic
molecules [62].
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Figure 3. Non-covalent interaction (NCI) plots for the four low-energy conformers of lovastatin identified from the potential
energy surface (PES) scans shown in Figure 1. The isosurfaces are drawn at a contour value of 0.05 and are colored using
the sign of the Laplacian. Blue represents H-bonding interactions (-ve Laplacian), green indicates van der Waals (vdW)
interactions (Laplacian close to zero), and red indicates steric interactions (+ve Laplacian). These images were prepared
using the Multiwfn [48] and VMD programs [49].
3.2. Vibrational Spectroscopy
The P212121 space group has the 222 (D2) point group with four irreducible represen-
tations (irreps), viz. A, B1, B2 and B3 (Table S1) [63]. Of these, all four may be Raman-active,
and the three B irreps may also be IR-active. Ignoring the zero-frequency acoustic modes,
the four molecules in the unit cell result in 3na − 3 = 777 vibrations, which span an irre-
ducible representation of 195 A + 194 B1 + 194 B2 + 194 B3 at the Γ-point. Therefore, as
previously reported [34], we anticipate up to 582 IR-active vibrations and 777 Raman-active
vibrations, which suggests that both types of spectroscopy could potentially provide rich
information about the conformations of molecules in the bulk crystal and at the crystal
surfaces, as well as information on functional group terminations at the crystal surfaces.
3.2.1. IR Spectroscopy
The IR spectrum collected from lovastatin powder is shown in Figure 4 together with
the solid-state spectrum from lattice dynamics modeling and the simulated spectra of each
of the four low-energy conformers identified in the gas-phase PES scans.
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Figure 4. Comparison of the infrared (IR) spectra of lovastatin powder (yellow) to the calculated spectrum of the solid
(purple) and the gas-phase spectra of the four low-energy conformers identified from the gas-phase potential energy surface
(PES) scans in Figure 1 (blue, green, black, red). The spectra are shown in three separate regions, viz. 2700–4000 cm−1
(a), 1400–1900 cm−1 (b) and 650–1500 cm−1 (c). The vertical black lines in (a) and (b) highlight differences in the position
of peaks among the gas-phase conformers with respect to the lowest-energy Conformer 1. The red box in (a) indicates
the changes in the C-H stretching in the four low-energy conformers. All six sets of spectra have been adjusted to similar
intensity scales.
In general, our measurements broadly agree with those reported in the literature [36],
and a full set of tentative assignments [64] can be found in Table 2.
The solid-state spectrum from lattice dynamics calculations is a good match with the
experimental spectrum, especially at low wavenumbers, although there is a notable shift
in the bands in the C-H and C=O regions. These wavenumber-dependent shifts may be
due either to a systematic error in the predicted frequencies, or to the fact that the single
optimized geometry that we performed the calculations on does not accurately reflect the
positional disorder in the crystal.
The calculated vibrational frequencies of the gas-phase conformers are generally
higher than those obtained from the solid-state calculations, which may be ascribed to
the intermolecular interactions present in the solid-state model but absent in the gas-
phase calculations—for example, the observed H-bonding and the CH· · ·HC and CH· · ·O
interactions [34]. In the measured spectrum, the pyranyl group C=O vibration occurs
at 1724 cm−1, 10 cm−1 higher than the S-butanoate C=O due to the effect of the ring
strain. These vibrations are predicted at 50–70 cm−1 higher wavenumbers in the gas-
phase calculations, which we again ascribe to the absence of intermolecular H-bonding.
Similarly, coupled C-O stretches at 1500 cm−1 in the gas-phase models appear at much
lower wavenumbers between 1050 and 1150 cm−1 in the solid state, again due to constraints
imposed by intermolecular H-bonding. The C=C symmetric stretching associated with
the diene functionality on the hexahydronaphthenyl group appears in the experimental
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spectrum as an intense band at 1698 cm−1. The solid-state calculation predicts a similar
intensity pattern, while the gas-phase spectra predict a very low intensity, which suggests
that interactions between hexahydronaphthenyl groups on adjacent lovastatin molecules
in the solid state give rise to appreciable changes in dipole moment. The presence of very
weak C-H overtone bands at ~2173 cm−1, together with the presence of vdW interactions
suggested by the NCI analysis, is further confirmation for the CH . . . HC interactions
previously suggested using INS studies [34].
Table 2. Tentative IR peak assignments for the reference experimental spectrum and the simulated spectra of solid-state
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Finally, weak features at 2323, 2343, 2362 cm−1 may suggest the presence of impurities
with free thiol groups (Figure S12). This is consistent with the ~0.5 wt. % of impurities
indicated by the manufacturer, which could include the S-H-containing malonyl-CoA
molecule [37]. The acid form of lovastatin is also known to sometimes be present as an
impurity [65], but we see no evidence for the presence of carboxylic acid monomers or
dimers in our measured spectra. There could also be a contribution to the C=C symmetric
stretch region of the spectrum from C=N vibrations of in malonyl-CoA impurities.
Having confirmed good agreement between the measurements and the simulated IR
spectrum of bulk lovastatin, we proceeded to compare our measurements to the calculated
spectra of the gas-phase conformers, to identify features that may signify differences in the
conformation of surface molecules.
The (110) and (020) crystal faces of lovastatin could potentially expose the O-H and
olefinic groups of the hexahydronaphthenyl moiety [2], depending on the choice of sol-
vent and preparation method. The solid-state calculations predict a sharp O-H stretch at
3538 cm−1, whereas the corresponding feature in the O-H stretch region of the experimental
spectrum is broader and less intense. This can be ascribed to the variable H-bond strength
between the O-H with C=O bond on the S-butanoate group in bulk, as well as to surface
groups in potentially different chemical environments. Of the four gas-phase conformers,
Conformers 1, 3 and 4 have the O-H group in a similar orientation to molecules in bulk,
whereas in Conformer 2, the bond is rotated by 180 ◦. This is predicted to shift the O-H
peak by 4 cm−1 in the gas phase compared to the other conformers, despite a negligible
10−3 Å change in the bond length. Since the O-H feature in the experimental spectrum is
considerably broader than this difference, we cannot discount the presence of Conformer 2
on the surface based on this peak position alone. Furthermore, the intensity patterns of the
peaks in the C-H stretching region between 3000 and 3200 cm−1, which contains olefinic
C-H and terminal CH3 stretches, are notably different between the measured and simulated
solid-state spectrum, even taking into account the nominal line broadening (10 cm−1) used
in the latter. The intensity pattern in the experimental spectrum is, however, very similar
to those predicted for the gas-phase Conformer 2 (marked by the green asterisk inside the
red box in Figure 4a), which supports appreciable amounts of this conformer being present
at the surface.
The lower-wavenumber C-H stretches at 2988 cm−1 and 2992 cm−1 in the gas-phase
conformers correspond to C-H stretches on the hexahydronaphathenyl group (C10 in
Figure 1e), suggesting that hexahydronaphthenyl groups may be exposed at the surface,
as indicated by the olefinic C-H stretches as well. These bands are present in the ex-
perimental spectrum but not in the calculated solid-state spectrum, which suggests that
hexahydronaphthenyl groups may be exposed at the surface.
The frequency and intensity pattern of the in-plane O-H and symmetric C-H deforma-
tions, which occur at 1246, 1261, 1297, 1329, 1360 and 1369 cm−1 in both the experimental
and simulated solid-state spectra, are also very similar to the gas-phase spectrum of Con-
former 2. The experimental spectra also show O-H out-of-plane deformations at 655 cm−1,
which are predicted at 656 cm−1 in the Conformer 2 spectrum but at 652 cm−1 in Con-
former 1. This provides further evidence for the possible presence of Conformer 2 on the
exposed crystal surfaces, or at least indicates that we cannot discount this possibility based
on the spectroscopy.
3.2.2. Raman Spectroscopy
The Raman spectrum of lovastatin powder is shown in Figure 5 alongside the cal-
culated solid-state spectrum and the calculated spectra of the four low-energy gas-phase
conformers. A full set of tentative assignments [64] can be found in Table 3.
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Figure 5. Comparison of the Raman spectra of lovastatin powder (yellow) to the calculated spectrum
of the solid (purple) and the gas-phase spectra of the four low-energy conformers identified from the
gas-phase potential energy surface (PES) scans in Figure 1 (blue, green, black, red). The spectra are
shown in four separate regions, viz. 2700–4000 cm−1 (a), 1600–1900 cm−1 (b) and 1100–1500 cm−1
(c) and 20–1100 cm−1 (d). The red box in (d) highlights differences in the C-O out-of-plane deforma-
tions. All six sets of spectra have been adjusted to similar intensity scales.
As observed in the IR spectra, the calculated solid-state spectrum broadly agrees with
the experimental measurements, but with the C-H vibrations and C=O stretches in the
latter occurring at lower and higher wavenumbers, respectively. The calculated Raman
spectra of the gas-phase conformers again highlight that the vibrations in the gas phase
generally occur at higher frequencies than in the solid state.
As in the IR spectra, the simulated solid-state Raman spectrum shows a clear O-H peak
at 3538 cm−1 which is not seen in the measured spectrum (Figure 5a). This discrepancy
could be due to our choice of a 1064 nm laser—since the Raman intensity scales as the fourth
power of the wavelength used [66], it is possible that there was insufficient photon flux to
excite this particular vibration. Notably, the intensity pattern of the C-H stretches predicted
from the solid-state calculations is similar to that of Conformer 1, whereas the intensity
pattern in the measured spectrum resembles a mixture of Conformers 1 and 2. The bulk
conformation is close to Conformer 1, albeit with a small conformational adjustment [9],
whereas our MD simulations suggested that the reoriented O-H bond in Conformer 2 is
likely to be strongly disfavored in the bulk. This observation is therefore again consistent
with Conformer 2 being present at the surface, as suggested by the IR spectra.
The C=C stretching peaks occur at 1647 cm−1 in the experimental spectrum (Figure 5b).
The gas-phase calculations predict that the C=O stretching at ~1808 cm−1 has much lower
intensity than the C=C stretching. This, together with the fact that the experimental data
were collected using a 1064 nm laser, could suggest that the C=O stretches were perhaps
not observed experimentally. In the calculated solid-state spectra, the C=O stretches appear
as broad shoulders at 1663 and 1676 cm−1.
Crystals 2021, 11, 509 16 of 23
Table 3. Tentative Raman peak assignments for the reference experimental spectrum (1064 nm) and the simulated spectra of
solid-state lovastatin and the four low-energy gas-phase conformers identified from the PES scan. Abbreviations: br—broad,















300, 292, 268 296, 284, 268 300, 280, 264 300, 280, 260
343 (sh), 347, 374,




376, 368, 356, 340,
316 (vw) 364, 356, 344, 368, 356, 340, 360, 348, 316
570, 536, 527, 490









584, 548, 536, 512,
488, 472, 432, 400
588, 560, 548, 528,
516, 508, 484, 472,
436, 404
588, 560, 548, 528,
508, 484, 472, 436,
404
616, 592, 560, 532,
516, 484, 464, 428,
416, 400
631 655 O-H out-of-planedeformation 652 640 640 656






788, 772, 756, 744,
720, 704, 652
796, 772, 756 (w),
740, 720 (sh), 708,
664
796, 772, 756, 744,
720, 708, 664
796, 756, 748, 720,
692
868, 829, 818 873, 831 Aliphatic C-CH3stretches
852, 840, 804 (sh),
800
844 (sh), 836 (sh),
832, 808 (sh) 848 (sh), 836, 808 860,856, 840, 812




988, 984 (sh), 960,
948, 932, 916, 884
984, 976, 960, 948
(w), 932 (w), 928
(w), 912, 896, 888
976 (sh), 960, 932
(w), 912 (w), 888
(w)















































































1384, 1376, 1360 1384, 1376, 1368,1364 1384, 1364 1372, 1352
1462 (sh), 1436,



























1704 (s), 1700 (sh)
1812, 1716 (sh),












































3828 3820 3828 3828
Crystals 2021, 11, 509 17 of 23
The thermal background noise in the spectra prohibits reliable identification of the
thiol groups observed in the IR measurements. Features in the fingerprint region from 1100
to 500 cm−1 also had a poor signal-to-noise ratio and could only be reliably discerned after
applying 7-point FFT smoothing to de-noise the spectra. The intensity patterns generally
resemble the calculated solid-state spectrum (Figure 5c). However, the smoothing of already
low-intensity features means that the peak positions may not be reliable, so we refrain from
making assignments. The intensity pattern of the C-O out-of-plane deformations between
300 and 400 cm−1 is similar to that predicted in the simulated solid-state spectrum and in
the simulated gas-phase spectrum of Conformer 1.
The prominent phonon peak at 110 cm−1 in the experimental spectrum (Figure 5d)
is notably absent in the solid-state calculations. There are several possible origins for this
discrepancy. The first is that PBE-D3 may incorrectly predict the change in polarizability
along the low-frequency modes. The second is that the calculations predict too high
an intensity for the strongest bands, so that the relative intensities of the phonon bands
are too weak. A third possibility is that the positional disorder in the real structure and
consequent symmetry breaking could allow for phonon modes away from the Brillouin
zone center to become Raman-active, resulting in an increase in the intensity that is not
accounted for in our calculations on a single unit cell. The phonon region of the lovastatin
vibrational spectrum has previously been investigated using terahertz spectroscopy [34]
and low-wavenumber Raman [28], and these studies found a generally good match between
experiment and theory. Our calculations are generally consistent with these previous
studies, with calculated vibrational modes at or close to features in the measured terahertz
and inelastic neutron scattering spectra in Ref. [34].
Overall, the Raman measurements do not provide a conclusive identification of the
conformer(s) present at the surfaces, but do support the inference from the IR measure-
ments that appreciable amounts of Conformer 2 may be present at the surface. Polarized
Raman experiments on single crystals with a shorter-wavelength laser might be used in
conjunction with modeling, as in our previous study [27], to better probe the functional
group orientations at the crystal surfaces. However, since lovastatin tends to form needle-
like crystals [67], growing single crystals with sufficient surface area for a typical beam
spot size is likely to prove challenging.
3.2.3. X-ray Photoelectron Spectroscopy (XPS)
Given its high surface sensitivity, we also investigated whether XPS measurements
might be useful for investigating surface conformations. As described in the Materials and
Methods section, the C1s and O1s spectra of the four low-energy conformers identified
from the gas-phase PES scans were calculated by treating the atomic energies obtained
using the method of Natural Atomic Orbitals as binding energies. We stress once again
that this is a very approximate method, and that binding energy shifts of 11.5 and 18 eV
needed to be applied to the C1s and O1s spectra, respectively, to match the experimental
energy ranges. We therefore use the calculations for qualitative comparison only.
Figure 6a,b show how the simulated C1s and O1s spectra of the lowest-energy gas-
phase conformer, Conformer 1, are obtained by summing contributions from the individual
atoms. The 11.5 eV shift adjusts the spectra so that the aliphatic C1s binding energy is
centered at a reference value of 285.0 eV, similar to the calibration method that we have
used in previous XPS studies of organic materials [68]. Similarly, the 18 eV shift applied to
the O1s spectra adjusts the C-O peak to match the typical binding energy of 534.5 eV.
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Figure 6. Simulated X-ray photoelectron spectra (XPS) of the four low-energy gas-phase conformers of lovastatin identified
from the potential energy surface scans. Plots (a,b) show how contributions from individual C and O atoms are combined
to form the simulated C1s and O1s spectra, respectively, for the lowest-energy conformer, Conformer 1. The spectra are
generated as a sum of Gaussian functions with unit area, centered on the NAO energies, and with a broadening of width
σ = 0.2 eV. An image of the molecule showing the atom labels is given in Figure 1e. Plots (c,d) compare the C1s and O1s
simulated spectra of the four conformers. The boxes highlight regions of the spectra where components are predicted to
have binding energy differences greater than 0.1 eV, which most likely could not be resolved experimentally due to being
much less than the natural linewidth.
After shifting, the C1s component from the C=C in Conformer 1 is predicted to occur
at around 284.5 eV, and the C1s peaks arising from aliphatic carbons are predicted to span
a range of 284.8–285.4 eV, centered at 285 eV (Figure 6a). The C-C-O C atoms are predicted
to give rise to C1s peaks at 285.8 eV, which is a 0.4 eV higher binding energy than the other
aliphatic carbons. The C1s peaks arising from the C-O atoms are predicted to produce
two distinct peaks at 286.8 eV and 287.4 eV, while peaks arising from O-C=O are centered
at 289.0 eV. In both cases where the C is bonded to an O, the peaks occur at a higher binding
energy for atoms in the pyranyl ring compared to those in the S-butanoate group. The
simulated O 1s spectrum of Conformer 1 (Figure 6b) shows features from the O-C=O atoms
centered at 531.5 eV, while those due to C-O atoms are centered at 534.5 eV.
The simulated C1s and O1s spectra (Figure 6c,d) of Conformers 1 and 3 are extremely
similar, while the C1s features from the C-C-O atoms in Conformer 2 are predicted to
shift to a 0.3 eV lower binding energy. However, the resulting changes to the overall C1s
spectrum, indicated by the black boxes in Figure 6c,d, are of the order of 0.1–0.3 eV and
may not be detectable. On the other hand, Conformer 4 shows a clear shift in the C1s and
O1s features arising from the C-O and O-C=O atoms of the S-butanoate group, which can
be related to the increased vdW interactions identified in the analysis in Figure 3, together
with a subtle increase in the C-O bond length (c.f. Table 1). These shifts are of the order
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of 0.5 eV or greater and hence likely could be detected experimentally if an appreciable
population of Conformer 4 were to be present.
The survey NAP XP spectrum of lovastatin (Figure 7a) indicates an elemental com-
position of 74.6% C and 11.5% O with 6.6% N and 7.3% Ar from residual air and charge
compensation gas, respectively. Based on the lovastatin stoichiometry, the elemental com-
position is expected to be 83% C and 17% O. Assuming that the entire O signal in the survey
spectrum can be attributed to lovastatin, there would be ~25 at. % excess C present. A com-
mon source of such excess C is adventitious carbon contamination from the environment,
which is commonly found [68] on materials that have been exposed to air. There may also
be impurities in the as-received material, such as N in malonyl CoA, as noted previously.
Figure 7. Near ambient pressure X-ray photoelectron spectra (XPS) of lovastatin powder: (a) survey scan; (b) high-resolution
C1s region; and (c) high-resolution O1s region.
The C1s core-level spectrum of lovastatin was analyzed by peak fitting using four
components, without constraints, reflecting the expected contributions of the four primary
C moieties in the molecule to the total peak area. These are as follows: 4 sp2 C atoms
in the in the two C=C bonds (17%), 15 sp3 aliphatic carbon atoms (62%), 3 C (12%) in a
single bond to a heteroatom (alcohol and ester) and 2 C atoms in the C=O carbonyl groups
(8%). The components have similar FWHM (~1.8 eV) except for the component reflecting
C atoms in the ester and alcohol functional groups, which has a slightly narrower FWHM
(1.3 eV). The narrower FWHM suggests that these C atoms are in more similar chemical
environments than the C atoms contributing to other components of the spectrum. The fit
approximates the relative theoretical contributions of the four clusters of functional groups
plus those from adventitious carbon to the spectral envelope. The fit also broadly agrees
with the trends in the calculated C 1s spectra of the gas-phase lovastatin conformers (c.f.
Figure 6c).
The O1s core-level spectrum was fitted with 2 peaks, with an equal FWHM broader
than those of the C 1s components, reflecting 3 O atoms at lower BE contributing 60% to the
total intensity and 2 O atoms at higher BE contributing to the remaining 40% of the overall
intensity. Based on the molecular structure of lovastatin, one expects the contributions
to be reversed, with the 2 O atoms from the carbonyl group contributing to the spectral
envelope at a lower binding energy than the 3 O atoms in the ester and alcohol species.
This result would also be in line with the relative contributions of these species observed in
the calculated O1s spectra. However, neither of these interpretations account for the impact
of non-covalent inter- or intramolecular interactions on the electron density of O atoms of
lovastatin in the solid state. For example, computational studies of crystalline lovastatin [2]
have identified that non-covalent intermolecular interactions involving the O atoms in
the carbonyl and alcohol functional groups make significant contributions to stabilizing
the crystal lattice. These include a short intermolecular contact between the carbonyl
and an acidic proton on adjacent pyranyl rings and a long H-bond between a carbonyl
group on the butanoate ester and an alcohol on an adjacent pyranyl ring. Redistribution of
electron density at the O atoms from these electrostatic interactions is well known to shift
the binding energies of the core-level electrons [69] by a similar magnitude to the shifts
observed in the O1s spectrum presented here. The relatively broader peaks in the O1s
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spectrum also suggest that the 5 O species might be distributed over more than just two
defined states. Resolving these details is, however, impossible without a better systematic
understanding of core-level binding energy shifts as a function of the exact proton positions
within the hydrogen bonds. The influence of these non-covalent interactions on the core-
level binding energies is stronger than the effects of conformational change (Figure 6),
and a deeper understanding of the dynamic and static disorder of protons, as well as the
depths of the PES of H-bonding, will be needed to identify the preferred conformation of
lovastatin in the solid state.
4. Discussion
Gas-phase conformational analyses of the main bond torsions identify four low-energy
conformers that would be expected to show appreciable populations at room temperature.
Analysis of the electrostatic potentials and non-covalent interactions does not suggest any
particular electrostatic interactions that would make one conformer lower in energy than
the other, so the energy differences likely arise from a subtle balance of intramolecular
interactions. The relative energies suggest a 21.8% occupation of a second conformer at
290 K, with the O-H group on the pyranyl ring pointing 180◦ to that in the other conformers.
Across the four low-energy gas-phase conformers, the two main chains of the molecule
comprising the S-butanoate and the lactone do not exhibit changes to any torsion that
are greater than 120◦, thereby concurring with previous studies [9] about the absence of
conformational polymorphism. Solid-state molecular dynamics simulations, on the other
hand, suggest that the O-H group is locked in position in bulk by a strong H-bonding
interaction with the neighboring C=O group. The disorder observed in the crystal structure
is instead due to the butyl group on the S-butanoate moiety, and the MD simulations
suggest co-operative movement molecules in adjacent unit cells along the short a direction.
A comparison of measured vibrational spectra to simulated spectra of bulk lovastatin
and the gas-phase conformations suggests that an appreciable amount of the second
conformer may be found at crystal surfaces, where the group is able to rotate freely. In
particular, the olefinic C-H stretching vibrations from the hexahydronaphathenyl group, the
coupled in-plane O-H deformation and symmetric C-H deformation and the appearance of
the out-of-place O-H deformation at 656 cm−1 in the experimental IR spectrum support the
presence of the second conformer at the surface. The intensity pattern of the C-H region in
the FT–Raman spectrum also suggests a combination of the two lowest-energy gas-phase
conformers, again supporting the presence of the second conformer at the surface. The
implication of this is that lovastatin crystal surfaces likely expose free O-H groups and are
therefore not chemically inert.
While experimental and computed XPS generally agree, we found little observable
difference between the two prominent low-energy gas-phase conformers. Better distinction
between conformers and impurities present on the true surface and sub-surface will
require more detailed studies using variable photon energy and angle-dependent XPS
experiments [70].
We also observed evidence in our measurements for the presence of malonyl CoA
impurities in our commercial lovastatin sample. XPS measurements indicate a small at. %
of N, which is difficult to identify in IR spectra due to the relatively weak N-H vibrations,
while S-H vibrations are evident in the IR spectra but are not observed in XPS due to the
lower sensitivity to S. These two measurements are therefore complementary.
Overall, the combination of gas-phase and solid-state modeling and spectroscopy has
provided valuable insight into the conformational flexibility of the lovastatin molecule in
bulk and at the particle surfaces, in a powder sample. In the future, our protocol could be
improved on by performing polarized Raman measurements, as well as angle-resolved
XPS measurements on clean single-crystal surfaces. This combined approach could be
applied to a wide range of molecular solids, and we therefore hope that our work will
serve as a first step towards a robust protocol for the routine analysis of particle surfaces.
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point group D2 (222), chemical environment in lovastatin molecule with atom labels, and calculated
XPS peaks as a function of various dihedral angles.
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